Shares of Khiron Life Sciences Corp. (CVE:KHRN – Get Rating) hit a new 52-week low during trading on Friday . The stock traded as low as C$0.11 and last traded at C$0.11, with a volume of 18200 shares changing hands. The stock had previously closed at C$0.11.
Analyst Upgrades and Downgrades
Separately, ATB Capital lowered their target price on shares of Khiron Life Sciences from C$0.60 to C$0.45 in a report on Tuesday, August 30th.
Khiron Life Sciences Stock Performance
The company’s fifty day moving average price is C$0.12 and its 200 day moving average price is C$0.16. The company has a market cap of C$23.80 million and a PE ratio of -0.57. The company has a debt-to-equity ratio of 7.84, a current ratio of 2.83 and a quick ratio of 1.34.
About Khiron Life Sciences
Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis.
- 3 Banks Worth Considering For Q4
- Stock Market: 3 Islands Of Strength In A Sea Of Red
- MarketBeat: Week in Review 9/12 – 9/16
- Is There a Cure for What is Ailing Teladoc Stock?
- No One Told These 3 Stocks It’s a Down Week
Receive News & Ratings for Khiron Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Khiron Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.